The T1/T2 Ratio is Associated With Resectability in Patients With Isocitrate Dehydrogenase-Mutant Astrocytomas Central Nervous System World Health Organization Grades 2 and 3.

Jonathan WellerEddie de DiosSophie KatzendoblerAlba CorellAnna DénesMichael Schmutzer-SondergeldNiloufar JavanmardiNiklas ThonJoerg-Christian TonnAsgeir Store Jakola

Published in: Neurosurgery (2024)

The T1/T2 ratio might be a good indicator for diffuse tumor growth on MRI and is associated with resectability in patients with IDH-mutant astrocytoma. This ratio might aid to identify patients in which an oncologically relevant tumor volume reduction cannot be safely achieved.

Keyphrases

wild type
end stage renal disease
newly diagnosed
low grade
chronic kidney disease
magnetic resonance imaging
prognostic factors
computed tomography
contrast enhanced
patient reported